Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
8.09%
Price
25.08.25
€108.00
Summary
This prediction is currently active. With a performance of 8.09%, the SELL prediction by Barclays_PLC for Novartis AG ADR is trending in the wrong direction Dividends of €3.87 are taken into consideration when calculating the performance. This prediction currently runs until 22.02.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novartis AG ADR | 1.408% | 1.408% |
| iShares Core DAX® | -0.347% | -0.149% |
| iShares Nasdaq 100 | -0.687% | 1.850% |
| iShares Nikkei 225® | -2.075% | 3.770% |
| iShares S&P 500 | 0.351% | 1.988% |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat